{"title":"Urinary Sodium and Potassium Excretion and the Risk of Cardiovascular Events in CKD.","authors":"Cass G G Sunga, Leila R Zelnick, Nisha Bansal","doi":"10.34067/KID.0000000943","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Kidney disease is a known, independent driver of cardiovascular disease. While dietary sodium and potassium intake, approximated via urinary excretion, are known cardiac risk factors in the general population, their role for prevention in persons with kidney disease is unclear. Thus, we studied the relationship between the ratio of urinary sodium-to-potassium excretion and incident cardiovascular disease in individuals with chronic kidney disease.</p><p><strong>Methods: </strong>We included 2,342 adults with chronic kidney disease enrolled in the Chronic Renal Insufficiency Cohort free of cardiovascular disease on study entry. Urinary sodium and potassium were measured via 24-hour urine collection at the baseline visit. Primary study outcomes included atrial fibrillation [AF], heart failure (overall, reduced ejection fraction [HFrEF] and preserved ejection fraction [HFpEF]), and myocardial infarction [MI]. Incidence rates (with 95% confidence intervals) were calculated per 1000 person-years. Nested models were created using Cox regression and adjusted for sociodemographic data (age, sex and race/ethnicity), lifestyle habits (body mass index and cigarette smoking), medication use, medical comorbidities and renal characteristics.</p><p><strong>Results: </strong>Among the study population, mean (SD) age was 56 (11) years and mean estimated glomerular filtrate rate was 51 (20) mL/min/1.73 m2. The highest quartile (versus lowest quartile) of urinary sodium-to-potassium ratio was associated with a 1.4-fold increased risk of overall HF (HR 1.44, CI 95% 1.05-1.98), 1.9-fold increased risk of HFrEF (HR 1.90, CI 95% 1.08-3.36) and 1.5-fold increased risk of AF (HR 1.48, CI 95% 1.03-2.13) after adjustment for the covariates above. We did not find an association with incident MI (HR 1.14, CI 95% 0.78-1.68) and HFpEF (HR 1.18, CI 95% 0.75-1.87).</p><p><strong>Conclusions: </strong>A higher ratio of urinary sodium-to-potassium excretion was associated with incident AF and HF (particularly HFrEF), but not MI, in persons with chronic kidney disease. Dietary sodium and potassium represent possible modifiable risk factors for cardiovascular disease prevention in individuals with kidney disease.</p>","PeriodicalId":17882,"journal":{"name":"Kidney360","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney360","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34067/KID.0000000943","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Kidney disease is a known, independent driver of cardiovascular disease. While dietary sodium and potassium intake, approximated via urinary excretion, are known cardiac risk factors in the general population, their role for prevention in persons with kidney disease is unclear. Thus, we studied the relationship between the ratio of urinary sodium-to-potassium excretion and incident cardiovascular disease in individuals with chronic kidney disease.
Methods: We included 2,342 adults with chronic kidney disease enrolled in the Chronic Renal Insufficiency Cohort free of cardiovascular disease on study entry. Urinary sodium and potassium were measured via 24-hour urine collection at the baseline visit. Primary study outcomes included atrial fibrillation [AF], heart failure (overall, reduced ejection fraction [HFrEF] and preserved ejection fraction [HFpEF]), and myocardial infarction [MI]. Incidence rates (with 95% confidence intervals) were calculated per 1000 person-years. Nested models were created using Cox regression and adjusted for sociodemographic data (age, sex and race/ethnicity), lifestyle habits (body mass index and cigarette smoking), medication use, medical comorbidities and renal characteristics.
Results: Among the study population, mean (SD) age was 56 (11) years and mean estimated glomerular filtrate rate was 51 (20) mL/min/1.73 m2. The highest quartile (versus lowest quartile) of urinary sodium-to-potassium ratio was associated with a 1.4-fold increased risk of overall HF (HR 1.44, CI 95% 1.05-1.98), 1.9-fold increased risk of HFrEF (HR 1.90, CI 95% 1.08-3.36) and 1.5-fold increased risk of AF (HR 1.48, CI 95% 1.03-2.13) after adjustment for the covariates above. We did not find an association with incident MI (HR 1.14, CI 95% 0.78-1.68) and HFpEF (HR 1.18, CI 95% 0.75-1.87).
Conclusions: A higher ratio of urinary sodium-to-potassium excretion was associated with incident AF and HF (particularly HFrEF), but not MI, in persons with chronic kidney disease. Dietary sodium and potassium represent possible modifiable risk factors for cardiovascular disease prevention in individuals with kidney disease.
背景:肾脏疾病是已知的心血管疾病的独立驱动因素。虽然饮食中钠和钾的摄入量(通过尿排泄来估计)是已知的一般人群的心脏危险因素,但它们在肾病患者中的预防作用尚不清楚。因此,我们研究了慢性肾病患者尿钠钾排泄比与心血管疾病发生率之间的关系。方法:我们纳入了2,342名成人慢性肾脏疾病患者,在研究开始时纳入无心血管疾病的慢性肾功能不全队列。在基线访问时通过24小时尿液收集测量尿钠和尿钾。主要研究结果包括心房颤动(AF)、心力衰竭(总体上包括射血分数降低(HFrEF)和射血分数保持(HFpEF))和心肌梗死(MI)。计算每1000人年的发病率(95%置信区间)。使用Cox回归建立嵌套模型,并根据社会人口统计数据(年龄、性别和种族/民族)、生活习惯(体重指数和吸烟)、药物使用、医疗合并症和肾脏特征进行调整。结果:在研究人群中,平均(SD)年龄为56(11)岁,平均估计肾小球滤液率为51 (20)mL/min/1.73 m2。调整以上协变量后,尿钠钾比最高四分位数(相对于最低四分位数)与总HF风险增加1.4倍(HR 1.44, CI 95% 1.05-1.98), HFrEF风险增加1.9倍(HR 1.90, CI 95% 1.08-3.36)和AF风险增加1.5倍(HR 1.48, CI 95% 1.03-2.13)相关。我们没有发现心肌梗死(HR 1.14, CI 95% 0.78-1.68)和HFpEF (HR 1.18, CI 95% 0.75-1.87)之间的关联。结论:在慢性肾病患者中,较高的尿钠钾排泄比与房颤和心衰(特别是HFrEF)有关,但与心肌梗死无关。饮食钠和钾代表了肾脏疾病患者预防心血管疾病的可能可改变的危险因素。